Budget impact analysis of PCSK9 inhibitors costs from a community payers' perspective in Apulia, Italy.

When considered from a large taxpayers' community perspective, relevant costs per cardiovascular event saved with PCSK9i may turn into very small individual costs per year. The selection of high-risk subgroups may further reduce individual costs.